PH12013000212A1 - Ampalaya banaba camote duhat (abcd tablet) - Google Patents
Ampalaya banaba camote duhat (abcd tablet) Download PDFInfo
- Publication number
- PH12013000212A1 PH12013000212A1 PH12013000212A PH12013000212A PH12013000212A1 PH 12013000212 A1 PH12013000212 A1 PH 12013000212A1 PH 12013000212 A PH12013000212 A PH 12013000212A PH 12013000212 A PH12013000212 A PH 12013000212A PH 12013000212 A1 PH12013000212 A1 PH 12013000212A1
- Authority
- PH
- Philippines
- Prior art keywords
- camote
- duhat
- banaba
- diabetes
- ampalaya
- Prior art date
Links
- 235000012097 Eugenia cumini Nutrition 0.000 title abstract description 15
- 244000234162 Eugenia cumini Species 0.000 title abstract description 14
- 239000000203 mixture Substances 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 9
- 229920002261 Corn starch Polymers 0.000 claims description 6
- 239000008120 corn starch Substances 0.000 claims description 6
- 229940099112 cornstarch Drugs 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 claims description 2
- 229960001021 lactose monohydrate Drugs 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 29
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 239000008103 glucose Substances 0.000 abstract description 16
- 241000196324 Embryophyta Species 0.000 abstract description 14
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 10
- 239000000470 constituent Substances 0.000 abstract description 7
- 230000009471 action Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000000321 herbal drug Substances 0.000 abstract description 4
- 230000007246 mechanism Effects 0.000 abstract description 2
- 239000011885 synergistic combination Substances 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 description 21
- 239000000284 extract Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 244000017020 Ipomoea batatas Species 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 14
- 244000060474 Eugenia jambolana Species 0.000 description 13
- 235000002678 Ipomoea batatas Nutrition 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000007423 decrease Effects 0.000 description 8
- 235000018553 tannin Nutrition 0.000 description 8
- 229920001864 tannin Polymers 0.000 description 8
- 239000001648 tannin Substances 0.000 description 8
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 8
- 235000010208 anthocyanin Nutrition 0.000 description 7
- 239000004410 anthocyanin Substances 0.000 description 7
- 229930002877 anthocyanin Natural products 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 150000004636 anthocyanins Chemical class 0.000 description 6
- 230000003178 anti-diabetic effect Effects 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- QNMKGMUGYVWVFQ-UHFFFAOYSA-N 2alpha-Hydroxyursolic acid Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3C(C)C(C)(C)CCC3(C(O)=O)CCC21C QNMKGMUGYVWVFQ-UHFFFAOYSA-N 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 229930003935 flavonoid Natural products 0.000 description 5
- 150000002215 flavonoids Chemical class 0.000 description 5
- 235000017173 flavonoids Nutrition 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 244000198896 Lagerstroemia speciosa Species 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000000401 methanolic extract Substances 0.000 description 4
- 230000036542 oxidative stress Effects 0.000 description 4
- 150000002989 phenols Chemical class 0.000 description 4
- 239000000902 placebo Substances 0.000 description 4
- 229940068196 placebo Drugs 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- FRWNAQDBODEVAL-VMPITWQZSA-N (5e)-5-[(4-nitrophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\1C(=O)NC(=S)S/1 FRWNAQDBODEVAL-VMPITWQZSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 244000302512 Momordica charantia Species 0.000 description 3
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 239000003472 antidiabetic agent Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 235000017807 phytochemicals Nutrition 0.000 description 3
- 229930000223 plant secondary metabolite Natural products 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- -1 triterpenoid glucoside Chemical class 0.000 description 3
- 230000002850 vibriocidal effect Effects 0.000 description 3
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 244000018716 Impatiens biflora Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- MXHMAVADCUBILS-UHFFFAOYSA-N Lagerstroemin Natural products OC1C2OC(=O)c3c1c(O)c(O)c(O)c3c4c(O)c(O)c(O)cc4C(=O)OC2C5OC(=O)c6cc(O)c(O)c(O)c6c7c(O)c(O)c(O)cc7C(=O)OCC5OC(=O)c8cc(O)c(O)c(O)c8Oc9cc%10C(=O)Oc%11c(O)c(O)cc%12C(=O)Oc(c9O)c%10c%11%12 MXHMAVADCUBILS-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002402 anti-lipaemic effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- HFGSQOYIOKBQOW-ZSDYHTTISA-N corosolic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C HFGSQOYIOKBQOW-ZSDYHTTISA-N 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- 230000010030 glucose lowering effect Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 235000012680 lutein Nutrition 0.000 description 2
- 239000001656 lutein Substances 0.000 description 2
- 229960005375 lutein Drugs 0.000 description 2
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 2
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 235000009048 phenolic acids Nutrition 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 2
- RIAWMGMFBMFEOP-UHFFFAOYSA-N 1-Epimer-Lagerstroemin Natural products OC1C2OC(=O)c3c1c(O)c(O)c(O)c3c4c(O)c(O)c(O)cc4C(=O)OC2C5OC(=O)c6cc(O)c(O)c(O)c6c7c(O)c(O)c(O)cc7C(=O)OCC5OC(=O)c8cc(O)c(O)c(Oc9cc%10C(=O)Oc%11c(O)c(O)c(O)c%12C(=O)Oc(c9O)c%10c%11%12)c8 RIAWMGMFBMFEOP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 102000011690 Adiponectin Human genes 0.000 description 1
- 108010076365 Adiponectin Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 244000183914 Dianthus superbus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000007877 Diospyros australis Nutrition 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 229940122355 Insulin sensitizer Drugs 0.000 description 1
- 101710190529 Insulin-like peptide Proteins 0.000 description 1
- RYMSMTOEKVDTDB-UHFFFAOYSA-N Lagerstroemine Natural products C12=C(OC)C(OC)=CC=C2C(N2CCCCC2C2)CC2OC(=O)CCC2=CC=C(O)C1=C2 RYMSMTOEKVDTDB-UHFFFAOYSA-N 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000010875 Prunus nigra Nutrition 0.000 description 1
- IBBBBSWWYCRDST-UHFFFAOYSA-N Reginin B Natural products OC1OC2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c(Oc5c(O)c(O)c(O)cc5C(=O)OC6COC(=O)c7cc(O)c(O)c(O)c7c8c(O)c(O)c(O)cc8C(=O)OC6C9OC(=O)c%10cc(O)c(O)c(O)c%10c%11c(O)c(O)c(O)c%12C(O)C9OC(=O)c%11%12)cc4C(=O)OC2C%13OC(=O)c%14cc(O)c(O)c(O)c%14c%15c(O)c(O)c(O)cc%15C(=O)OC1%13 IBBBBSWWYCRDST-UHFFFAOYSA-N 0.000 description 1
- 235000014548 Rubus moluccanus Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000018288 Vitex doniana Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000001032 anti-candidal effect Effects 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 108010054251 arabinogalactan proteins Proteins 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229930185803 charantin Natural products 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000016396 cytokine production Effects 0.000 description 1
- 239000002027 dichloromethane extract Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 229920001968 ellagitannin Polymers 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 238000007446 glucose tolerance test Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 230000004121 glycogenesis Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000002660 insulin-secreting cell Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- MXHMAVADCUBILS-IIJWOKRGSA-N lagerstroemin Chemical compound O([C@H]1[C@@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C4=C3C(=O)O[C@H]2[C@@H]4O)C(=O)C2=CC(O)=C(O)C(O)=C2C2=C(O)C(O)=C(O)C=C2C(=O)OC[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1OC1=CC(C(O2)=O)=C3C4=C2C(O)=C(O)C=C4C(=O)OC3=C1O MXHMAVADCUBILS-IIJWOKRGSA-N 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000006680 metabolic alteration Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000007410 oral glucose tolerance test Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
ABCD (amplaya, banaba, camote,duhat) is a pioneering herbal drug that combines the four widely used herbals for diabtes. Biologically active constituents found in these plants that have clinically demonstrated hypoglycemic properties, or other actions of potential benefit against diabetes mellitus are summarized and tabulated below to have a better perspective on how the four components can work individually thru their respective mechanisms of action, or together in synergistic combination thru their similarly shared active constituents toward a common goal in controlling the blood glucose level in a diabetic patient.
Description
. be 2]
HERBAL DRUG AGAINST DIABETES USING .
AMPALAYA, BANABA, CAMOTE, AND DUHAT os
ABCD (ampalaya, banaba, camote, duhat) is a : pioneering herbal drug that combines the four widely - used herbals for diabetes. Biologically active - constituents found in these plants that have clinically - demonstrated hypoglycemic properties, or other actions of potential benefit against diabetes mellitus are summarized and tabulated below to have a better perspective on how the four components can work individually thru their respective mechanisms of action, or together in synergistic combination thru their similarly shared active constituents toward a common goal in controlling the blood glucose level in a diabetic patient
Background of the study:
A thorough and comprehensive introduction for this pioneering herbal drug cannot be done without discussing each individual component and how they could possibly work together synergistically to achieve - optimum and better diabetes control. N
AMPALAYA ;
To date, close to 100 in vivo studies have - demonstrated the blood sugar-lowering effect of - ampalaya. The fruit has also shown the ability to 7 enhance cells’ uptake of glucose to promote insulin release, and to potentiate the effect of insulin. It contains an array of biologically active plant chemicals including treiterpenes, proteins, and steroids. In numerous studies, at least 3 different groups of constituents found in all parts of ampalaya have clinically demonstrated hypoglycemic (blood sugar lowering) properties or other actions of potential benefit against diabetes. These chemicals that lower blood sugar include a mixture of steroidal sapponins known as charantins, insulin-like peptides, and alkaloids. The hypoglycemic effect is more pronounced in the fruit where these chemicals are ound in greater abundance.
Recent experimental investigation by Fernandes et al (2007) with respect to the mechanism of actions of
- bo -
M. charantia extract in diabetic rats suggest that it enhances insulin secretion by islets of Langerhans (the :. insulin secreting cells of the pancreas). Thus it reduces - glycogenesis in liver tissue, enhances peripheral glucose 2 po utilization and increases serum protein levels, =
Furthermore, treatment restores the altered histological architecture of the islets of Langerhans. Therefore, the biochemical, pharmacological, and histopathological profiles of ampalaya extract clearly indicate its potential antidiabetic activity and other beneficial effects in amelioration of diabetes-associated complications.
Aside from the already mentioned benefits, an evaluation of the plant’s antilipidemic activity in old obese rats demonstrated significant lowering of cholesterol and triglyceride levels while elevating HDL cholesterol aka good cholesterol levels. Also, the extract lowered serum lipids in diabetic rats suggesting its usefulness in controlling metabolic alterations associated with diabetes.
A more recent study by Bhujbal et al in 2011 evaluated the efficacy of transdermal patches of M.
En . i. 5] charantia in diabetic rats. The patches’ thickness of :. 2cm? roughly equivalent to 10 mg/patch gave a . percentage release of active constituents from the patches of 47.59% in 10% hydroalcoholic phosphate a buffer pH of 7.4 at the end of 6 hours. The transdermal p route gave negligible skin irritation. And in vivo results ) revealed that the patches successfully decreased the i blood sugar level.
Aside from the fruit, the seeds of ampalaya through its active constituents — poplypeptide k and oil isolated from the former showed potent inhibition of [- glucosidase enzyme (79.18% inhibition for polypeptide k, 53.55% inhibition for seed oil) in a study by Ahmad et al (2012). These suggest that both popypeptide k and seed oil from M. charantia are potent potential hypoglycemic agents. A more comprehensive experiment in India by Srivastava et al showed an aqueous powder extract of the fresh unripe whole fruit of M. charantia reduced fasting glucose by 48% comparable to glibenclamide ( a known synthetic antidiabetic drug).
oo
Ampalaya is contraindicated during pregnancy. Bn
It traditionally has been used as an abortive, and has been documented to have weak uterine stimulant » activity. The plant has also been documented to reduce i. 5 fertility in both males and females and should therefore not be used by those undergoing fertility treatment or - seeking pregnancy. It is also contraindicated in women who are breastfeeding. All parts of ampalaya especially the fruit and seed have demonstrated in numerous in vivo studies that they lower blood sugar levels. As such, it is contraindicated in persons with hypoglycaemia.
Diabetics should check with their physicians before using this plant, and use with caution while monitoring their blood sugar levels regularly as the dosage of hypoglycemic medications and insulin may need adjusting.
BANABA
The second component of our herbal combo is
Banaba (Lagerstroemia speciosa). A plant or tree that grows wild and is widely distributed in the Philippines.
It is also cultivated for its beautiful flowers. As such, its
> ow
So
I common name Queens Flowers in English is apt for its Es large pink to lavender oblong-obovate-shaped blooms. .
The leaf of banaba is official in the Philippine ol
Pharmacopeia. It is high in corosolic acid or colosolic i. acid, a triterpenoid glucoside, and contains 3 ~ ellagitannins. Namely, lagerstroemin, flosin B, and - reginin A. The plant’s corosolic acid content has been studied for glucose lowering effect. The plant as a whole is rich in tannin which gives it a whole new dimension in as far as having other pharmacologic significance e.g., anticarcinogenic, anti-oxidant, and antibacterial/antiviral/antifungal properties. Tannins have also been reported to exert other physiological effects such as to accelerate blood clotting, reduce blood pressure, decrease serum lipid level, and modulate immune responses.
One of the more popular folkloric uses of banaba is its leaf decoction used in the management of diabetes; also as a diuretic and purgative. For this, a decoction of old leaves and dried fruit (dried from 1-2 weeks) is mixed to 50 grams in a pint (550 ml) of
=
En @ boiling water; then taken 4-6 cups daily for diabetes. RS
Old leaves and ripe fruit are preferred which are . believed to have greater glucose lowering effect. A o decoction of 20 grams of old leaves or dried fruit in 100 . ml of water was found to have the equivalent effect of - 6.0 — 7.7 units of insulin.
As mentioned earlier, the ability of this plant to lower blood glucose is attributed to its corosolic content. Studies in mice conducted by Kakuda et al suggests that extracts of L. speciosa have beneficial effects on control of the level of plasma glucose in non- insulin dependent diabetes. For example, hemoglobin
Alc of HbAlc was found to be suppressed at the end of the experiment in the group treate with L. speciosa : extract. Meanwhile, a study by Suzuki et al showed that mice fed with banaba extract also howed a sisgnificant decrease = 65% of the control level in total hepatic lipid contents. These results suggest that banaba has anti- obesity effects as well.
A randomized clinical trial conducted by Judy et al involving patients with type II diabetes assessed the
A _
Lo fo o antidiabetic activity of an extract of L speciosa leaves Fe standardized to 1% corosolic acid (Glucosol). Findings . revealed that at daily doses of 32 and 48 mg, a y significant decrease in blood glucose levels was = observed in diabetic patients after only two weeks of -
Glucosol intake.
According to the Philippine Pharmacopoeia 2004, pregnant women, nursing mothers, and children : should avoid intake of banaba products. And that patients with hypoglycaemia should also avoid taking any prparations of L. speciosa leaf. ]
CAMOTE
Ipomoea batatas or camote 1s sweet potato in
English. It is cultivated extensively throughout the
Philippines as a cheap source of carbohydrates especially among the rural and urban poor. It has a higher nutritional value than the common potato. A good source of vitamin A, B, C, iron. Calcium, and phosphorus. It is high in complex carbohydrates and ] dietary fiber. The leafy tops are eaten as vegetables, a component of many traditional cuisines. Although
» technically a root crop of agricultural importance, it is - the leaves that holds medicinal value. They have a high . content of polyphenolics — anthocyanins and phenolic - acids. With at least 15 biologically active anthocyanins ~ with medicinal value. -
Phytochemical screening conducted by -
Pochapski et al on the crude extract fractions of
I.batatas leaves yielded positive for several phytochemical classes — treterpenes/steroids, alkaloids, flavonoids, saponins, tannins, phenolic acids to name a few. Numerous other compounds have also been isolated of varying significance. Steed and Traong conducted a study which included quantifying the anthocyanin and phenolic content of purees of purple- fleshed I. batatas. A study by Chandrika et al quantified the carotenoid and lutein content of selected green leafy vegetables that were popular in Sri Lanka. Camote leaves had the highest beta carotene content (743.9 + 33.0 ug/g/dry wt) while the lutein content was also found to be relatively high (1685.8 + 101.7 ug/g/dry oo : 10
Cn
Camote leaves have traditionally been used for Fe diabetes by eating the top after being cooked by . blanching or as garnishing in fish stew. Hot water - infusion of the whole plant is also used in southwest on
Nigeria. The crushed leaves are applied to boils and . ] acne while the boiled roots are eaten for diarrhea. The tea from scalded or dried slices of the tubers is used to ally thirst in China.
Severa studies have explored the activity of
Ipomoea batatas against diabetes. In a study by Li et al after obtaining the optimal extraction parameters of flavonoids from Ipomoea batatas leaves, the flavonoid- rich preparations was used to treat alloxan-induced diabetic mice. Results showed that treatment for 28 days significantly decreased fasting blood glucose levels. In addition, there was also an observed significant decrease in total cholesterol and triglycerides, while increasing body weight and serum
HDL (good cholesterol). Optimal dose was determined at 100 mg/kg body weight.
C1 i
A study by Ozaki et al revealed that continuous . administration of an arabinogalactan protein isolated . from the tuberous cortex of the white skinned camote to > experimental mice significantly lowered the fasting on plasma glucose. Oki et al followed up on this study with - a separate investigation on the protein’s effect on - hyperglycemia in mice. Their findings include significantly decreased plasma glucose levels after an oral glucose tolerance test. As well as an increae in : insulin sensitivity based on an insulin tolerance test.
This indicates that the hypoglycemic activity of the protein maybe due to a reduction in insulin resistance. i
A study by Niwa et al also observed significant decreases in fasting blood glucose. As well as HbAlc levels in streptozotocin-induced diabetic rats fed with powdered Ipomoea batatas for 2 months. On the other hand, based on their analysis of markers of anti-oxidant activity including histological studies of the pancreas, they proposed that the hypoglycemic effects of Ipomoea batatas result from the suppression of oxidative stress and pro inflammatory cytokine production, along with os an improvement of pancreatic B-cell mass. A systematic - review and meta analysis of the effects of herbal supplements on glycemic control in type II diabetes was : conducted by Suksomboon et al. Based on the current - evidence, they concluded that supplementation wth -
Ipomoea batatas among other medicinal plants may - improve glycemic control in patients with type II diabetes.
Similar to other herbals, camote has other biologic activities as well. Other researchers have focused on its anti-oxidant, anti-inflammatory, hepatoprotective, antineoplastic, and antilipidemic properties. One study worth mentioning here is the one by Park et al regarding the anti-oxidant activity of anthocyanins from I. batatas. Much evidence showed that the latter can protect against the adverse effects 1 brought about by the oxidation lipids usually from a high cholesterol diet. Included in their findings is the in vitro activity of ethanol and eater extracts from purple
Ipomoea batatas against atherosclerosis secondary to the oxidation of lipids. In addition, they also found that
- it protected against protein glycation, which is a known - risk factor for diabetes mellitus. Whereas, Miyazaki et po
Ln al have shown that the ability of anthocyanins from o
Ipomoea batatas to suppress atherosclerotic lesions and ; oxidative stress markers in mice occurs independently - of changes in cholesterol and lipid levels.
A randomized, cross over clinical trial by Chen et al on 16 healthy adults was able to show that the intake or consumption of purple Jpomoea batatas leaves decreased lipid peroxidation and DNA damage. Their result suggests that the polyphenols in the camote leaves were bioavailable as evidenced by an increase in total phenol excretion after 2 weeks of the treatment period.
Also, low density lipoprotein (LDL) lag time and glutathione concentration in erythrocytes after the treatment period was significantly enhanced by 15.0 and 33.3%, respectively. These findings indicate the potential of camote leaves to increase anti-oxidant defense and decrease oxidative stress in humans.
Finally, a randomized clinical trial conducted by
Ludvik et al observed 27 patients with type II diabetes bo who received 4 grams of Ipomoea batatas leaves for 5 - months, and 34 patients who received placebo. The fo
Ln study’s findings confirm the beneficial effects of -
Ipomoea batatas on glucose and HbAlc control in patients with type II diabetes after 5 months of follow - up. Also observed was improvement in insulin = sensitivity, along with increased levels of adiponectin and a decrease in fibrinogen. These results suggest that
Ipomoea batatas works as a natural insulin sensitizer with potential anti-atherogenic properties.
No known contraindications regarding the consumption of camote root crop. However, the : leaf/tops as seen to have hypoglycemic effect is therefore, recommended for known and suspected diabetics especially those under hypoglycemic medications to take the necessary precautions in adjusting their doses with the advice of their physicians.
DUHAT
Duhat or Syzygium cumini is a smooth tree about 8 to 15 meters high. It is found throughout the
Philippines. Of special interest is the oval dark purple or
- bo nearly black fruit. It is luscious, fleshy, and edible with - a sweet astringent taste containing a single large seed. por a
Thus it is also known as “black plum” in English. It’s ~ one of the more popular fruits in the Philippines - especially during summer. The ripe fruit is eaten - . outright. The juice from the fruit can be made into wine + or vinegar. And is a good source of calcium and iron.
The fruit, leaves, and tree bark are of medicinal importance. Recent phytochemical screening conducted by Soni et al on the ethanol extract from the leaves of S. cumini in India yielded positive for glycosides, tannins, phenolic compounds, and carbohydrates. While an earlier screening by Ugbabe et al on the methanol extract from the leaves in Nigeria yielded positive for flavonoids, saponins, terpenes, sterols, tannins and phenols; as well as balsams, resins, carbohydrates, and volatile oils. Whereas the methanol extract from the stem/bark yielded positive for flavonoids, saponins, terpenes, sterols, tannins, phlobotannins, and phenols; as well as balsam, resins, and carbohydrates. The S. cumini bark 1s official in the Philippine Pharmacopoeia.
. Co - ro
A quantitative mineral analysis of the fruit was - conducted by Benherial an Arumughan. And their result showed that calcium was abundant in all fruit parts and ; extracts. In the fruit pulp total phenolics were ) determined at 3.9 = 0.5 g/kg; anthocyanins 1.34 = 0.2 - g/kg, while flavonoid contents at 0.07 £0.04 g/kg. -
Whereas, kernel and seed coat contained 9.0 + 0.07 g/kg and 8.1 = 0.8 g/kg total phenolics, respectively.
Traditionally in the Philippines, duhat has had its share of folkloric uses. The decoction of the bark is used for dysentery; as mouthwash/gargle for oral ulcers and gingivitis; as astringent wash for external wounds, and as enema. The ripe fruit is astringent and considered as efficient remedy for diabetes. Decoction of leaves and bark also used for diabetes, but the ripe fruit is considered the best. If in season (summer) a person with diabetes may reportedly eat the ripe fruit at leisure.
Quisumbing cites Guerrero who states that the pulverized dried seeds are also useful in diabetes.
Laboratory and nonclinical studies on the biologic acitivity of duhat have been done especially
. RY oo with regard to its anti-oxidant, anti-inflammatory, Ea antimicrobial, and antidiabetic effects.
Several studies . have investigated the anti-oxidant properties of duhat . which evaluated the activity based on the phenolic - ]
contents of the seeds and leaves.
One study worth o mentioning here is the one by Abdalla et al which assessed the effect of the aqueous seed extract on oxidative stress induced by methyl mercury in neonatal rats.
Methyl mercury has been known to be a toxic environmental pollutant which can cause dysfunction in many cell types.
In this study they determined that the seed extract was able to revert the toxic effects of methyl mercury in the animal subjects; as evident in the better levels of certain enzymes in the brain, liver, and kidney.
The study attributed this to the main compound present in the aqueous seed extract, namely gallic acid, chlorogenic acid, and ratin.
These are all phenolic compounds.
Other studies isolated tannins from the fruit and suggested the use of the fruit as a significant source of natural anti-oxidants.
They also showed a significant ] correlation between extract concentration and
. 18 oo
Co percentage of free radical inhibition or lipid . peroxidation. Authors suggest the anti-oxidant property - of the fruit skin may come in part from the anti-oxidant ; vitamins, phenolics, tannins, and anthocyanins present - in the fruit. -
The antimicrobial biologic activity of duhat has " also been evaluated. Of particular interest here is the antibacterial property experimented by Sharma et al wherein, they screened several medicinal plants in vitro for vibriocidal activity against 12 isolates of Vibrio cholera. They found that the water, acetone, and ethanol extracts of duhat exhibited one of the highest vibriocidal activity against most of the strains tested. They study concludes that among the medicinal plants screened, S. cumini has the potential to be a broad spectrum vibriocidal agent. Hofling et al evaluated the antifungal activity of selected plant extracts against different species of Candida. Included in their study was the assessment of the dichloromethane and methanol extracts from the seeds of S. cumini. Both showed strong antifungal activity against the tested strains.
.
Especially the methanol extract which consistently and He significantly inhibited all strains of Candida used in the . study. The study suggests that S. cumini is a potential - source of anticandidal therapeutic agent. a
Several studies have probed into the antidiabetic . activity of duhat particularly due to its popular use in traditional medicine systems in the treatment of diabetes. In a study by Shinde et al, they demonstrated the seed kernel extracts to exhibit [I-glucosidase inhibitory activity in vitro, a property which decreases glucose absorption from the digestive tract. Similarly, different studies have shown the inhibitory activity of duhat seed extracts on pancreatic [J-amylase in vitro which may also be beneficial to the management of diabetes. In addition, studies by Bopp et al and De Bona et al have shown inhibitory effect in vitro of S. cumini leaf extracts on adenosine deaminase activity, and improve antioxidant status in the serum of diabetic : patients. Both of which are associated with improving blood sugar control and mitigating long term complications of diabetes.
- fru?
Though a number of studies as mentioned above - have provided evidence suggestive of antidiabetic - activity of S. cumini, Texeira et al have conducted : studies that indicate the absence of antidiabetic activity - of S. cumini. In a randomized, parallel, placebo - controlld trial employing a tea prepared from S. cumini . leaves, no significant antihyperglycemic effect was observed in 30 nondiabetic, young volunteers who took a blood glucose tolerance test, whereas, in a randomized double blind, double dummy controlled trial on patients with type II diabetes, Texeira et al also found no significant effect on the fasting blood glucose of patients who received treatment with the tea prepared from S. cumini leaves nor from placebo. They report 27 patients who were followed for 28 days. After which, the study found that the fasting blood glucose levels significantly decreased in the group which received an oral hypoglycemic (Glyburide); while no such effect was found in groups that received S. cumini tea or placebo.
po ol
The active ingredients of the inventions are: he
Ampalaya leaf powder - 2.25kg
Banaba leaf powder - 2.25kg gi
Camote leaf powder - 0.25kg
Duhat leaf powder - 0.25kg
Cornstarch - 0.20kg
Lactose Monohydrate - 0.20kg
The ingredients are passed through stainless steel screen mesh #30. Then loaded into Sigma-Bio mixer and mixed for 15-20minutes. In a separate suitable stainless steel container mix cornstarch 0.96kg to Purified water 1.5L, disperse completely the cornstarch with continuous mixing. Into a steam jacketed kettle, purified water 3.6 Liters is heated up to 90-95° . Add the cornstarch and water mixture ! to the heated water gradually with continuous mixing until a uniform translucent paste is obtained. Wet the ingredients mixture from the bio mixer by gradually on
Jon adding the translucent paste (water and cornstarch), . with continuous mixing until a uniform damp mass is . obtained. Pass the wet mass through stainless steel . screen mesh #4, and load into the Fluid Bed Dryer. Dry ) the bulk mass at 60°c until a moisture content 2-4% is - obtained. -
Check the relative humidity and temperature of the room. Ensure that the relative humidity should not be more than 55%, and the temperature should not be more than 28°. Resize the dried granules using Fitzmill fitted with stainless steel screen mesh #20, and load into the V-blender, and mix for 15 minutes. Pass the mixture through stainless steel screen mesh #80; add magnesium stearate 0.04kg or 40gms. Premix into a 0.5kg portion of the bulk mixture using a suitable P. E (polyethylene) bag and mix. Load into the V-blender and mix for 5 minutes.
The bulk mixture is compressed into tablets under specified parameters.
fo
1. Check color and consistency of bulk powder- .
green to dark green granules with characteristics . odor. o 2. Check the punches and dies of the tableting . machine. o
3. Check the following during -
compression: - Tablet weight ; 640 mg + 5% - Tablet thickness 6.70 to 7.20 mm - Tablet length ; 15.5 mm to 15.90 mm - Friability : not more than 1.0%
: - Moisture content : 2- : 4% - Enable hardness 7- 15kgb :
= - Disintegration test: . not more than 30 pe
Loa minutes J foe ee fu, 4
Claims (4)
1. A Pharmaceutical composition containing: .
a. Ampalaya leaf powder - 225mg or 45% . by volume as active ingredients .
b. Banaba leaf powder - 225mg or 45% - by volume :
C. Camote leaf powder - 25mg or 5% by i volume ingredients d. Dubhat leaf powder - 25mg or 5% by | volume as active ingredients Said composition is distributed in a suitable vehicle to be formulated into a tablet.
2. A Pharmaceutical formulation/composition according to claim 1 wherein 14-18% by weight of cornstarch was used.
3. A Pharmaceutical formulation/composition according to claim 1 wherein 2-3% by weight of : Lactose monohydrate was used.
4 A Pharmaceutical formulation/composition according to claim 1 wherein 8% by weight of magnesium stearate was used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH12013000212A PH12013000212A1 (en) | 2013-07-08 | 2013-07-08 | Ampalaya banaba camote duhat (abcd tablet) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PH12013000212A PH12013000212A1 (en) | 2013-07-08 | 2013-07-08 | Ampalaya banaba camote duhat (abcd tablet) |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12013000212A1 true PH12013000212A1 (en) | 2015-01-12 |
Family
ID=52594732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12013000212A PH12013000212A1 (en) | 2013-07-08 | 2013-07-08 | Ampalaya banaba camote duhat (abcd tablet) |
Country Status (1)
Country | Link |
---|---|
PH (1) | PH12013000212A1 (en) |
-
2013
- 2013-07-08 PH PH12013000212A patent/PH12013000212A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kumar et al. | Systematic pharmacognostical, phytochemical and pharmacological review on an ethno medicinal plant, Basella alba L | |
Ali et al. | 26 Nutritional and medicinal | |
Das et al. | Okra and its various applications in drug delivery, food technology, health care and pharmacological aspects-a review | |
Mohamed et al. | The antihyperglycaemic effect of the aqueous extract of Origanium vulgare leaves in streptozotocin-induced diabetic rats | |
Khan et al. | A review-Phytomedicines used in treatment of diabetes | |
Sarma et al. | A pharmacological perspective of banana: Implications relating to therapeutic benefits and molecular docking | |
Senevirathne et al. | Ceylon cinnamon: a versatile ingredient for futuristic diabetes management | |
Panossian et al. | From traditional to evidence-based use of Hippophae rhamnoides L.: chemical composition, experimental, and clinical pharmacology of sea buckthorn berries and leaves extracts | |
Usai et al. | Natural products for the treatment and management of diabetes mellitus in Zimbabwe-a review | |
Walia et al. | Role of Amla in type 2 diabetes mellitus-A Review | |
KR100831621B1 (en) | The plant extracts composition for the blood glucose reducing action | |
KR100762448B1 (en) | A herbal mixture extract comprising adenophora tripylla and food supplement comprising the same for prevention and treatment of liver disease | |
Tayyab et al. | A review: Medicinal plants and its impact on diabetes | |
Garba et al. | Effect of methanolic extract of Cassia occidentalis L. root bark on body weight and selected biochemical parameters in alloxan induced diabetic rats | |
EP1369123A1 (en) | A health-care product comprising lotus rhizome and process for its preparation | |
Elmaadawy | Phyto-extracts applied in beef meatballs ameliorates hyperglycemia and its complications in alloxan-induced diabetic rats | |
Gupta et al. | Nutraceuticals for diabetes and glucose balance | |
KR100293890B1 (en) | Food composition for control of body weight and blood sugar prepared by using Dong-A Green Juice and its residue | |
Alexiou et al. | Medicinal plants used for the treatment of diabetes and its long-term complications | |
Akabari et al. | Ethanopharmacology, Phytochemistry, Pharmacology and Toxicology of Moringaceae Family: A Review. | |
KR20120089045A (en) | A composition comprising powder of amphicarpaea bracteata subsp.edgeworthii(benth.) h.ohashi and the extract thereof for preventing and treating diabetes mellitus and diabetic complication | |
KR100865900B1 (en) | Composition comprising an extract of herbal combination(occ-i) or the powder(occ-ii) thereof for preventing and treating diabetes mellitus | |
KR100846521B1 (en) | Composition comprising an extract of herbal combination(oca-i) or the powder(oca-ii) thereof for preventing and treating diabetes mellitus | |
PH12013000212A1 (en) | Ampalaya banaba camote duhat (abcd tablet) | |
Jere et al. | Phytochemical studies and blood glucose lowering effect of Zambian cultivars of Piliostigma thonningii in alloxan-induced diabetic rats |